Inventor

EMONDS-ALT XAVIER

FR47 patents

⚠️ This page may combine multiple inventors who share the name “EMONDS-ALT XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EMONDS-ALT XAVIER

SANOFI SA

Arylalkylamines, process for preparing them and pharmaceutical compositions containing them

Aromatic amine compounds their method of preparation and pharmaceutical compositions in which they are present

Arylalkylamines, process for preparing them and pharmaceutical compositions containing them

Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present

Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation

Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation

Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

Substituted heterocyclic compounds and pharmaceutical compositions in which they are present

Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present

Heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present

Process for preparing N-alkylene piperidino compounds and their enantiomers

1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present

1-azoniabicyclo[2.2.1] heptanes and pharmaceutical compositions in which they are present

Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them

Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present

Substituted heterocyclic compounds

Process for preparing stereo isomers of neurokinin receptor antagonists

Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present

Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present

Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present

Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them

Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present

Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them

Piperidine derivatives process for obtaining them and pharmaceutical compositions containing them

Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them

Salts of substituted nitrogenous heteroaromatic compounds, a process for their preparation and pharmaceutical compositions containing them

Substituted arylaliphatic compounds, method of preparing them and pharmaceutical compositions in which they are present

SANOFI SYNTHELABO

Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present

Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them

Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them

1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives

Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders

Osanetant in the treatment of depression and depressive disorders

Ureidopiperidine derivatives as selective human NK3 receptor antagonists

SANOFI ELF

Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present

Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present

Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them

Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present

Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present

Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present

SANOFI AVENTIS

Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them

4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof

Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders